SB743921 200mg | 96.32% APEXBIO TECHNOLOGY LLC Potent KSP inhibitor Cell Cycle/Checkpoint|Ksp More Information Supplier Page × SB743921
Ki16198 10mM (in 1mL DMSO) | 98.05% APEXBIO TECHNOLOGY LLC LPA antagonist GPCR/G protein|LPA Receptor More Information Supplier Page × Ki16198
Ki16198 Evaluation Sample | 98.05% APEXBIO TECHNOLOGY LLC LPA antagonist GPCR/G protein|LPA Receptor More Information Supplier Page × Ki16198
Ki16198 5mg | 98.05% APEXBIO TECHNOLOGY LLC LPA antagonist GPCR/G protein|LPA Receptor More Information Supplier Page × Ki16198
SB743921 10mg | 96.32% APEXBIO TECHNOLOGY LLC Potent KSP inhibitor Cell Cycle/Checkpoint|Ksp More Information Supplier Page × SB743921
Pacritinib (SB1518) 50mg | 99.11% APEXBIO TECHNOLOGY LLC JAK2/FLT3 inhibitor More Information Supplier Page × Pacritinib (SB1518)
Pacritinib (SB1518) 25mg | 99.11% APEXBIO TECHNOLOGY LLC JAK2/FLT3 inhibitor More Information Supplier Page × Pacritinib (SB1518)
Pacritinib (SB1518) 10mg | 99.11% APEXBIO TECHNOLOGY LLC JAK2/FLT3 inhibitor More Information Supplier Page × Pacritinib (SB1518)
Pacritinib (SB1518) 5mg | 99.11% APEXBIO TECHNOLOGY LLC JAK2/FLT3 inhibitor More Information Supplier Page × Pacritinib (SB1518)
IMD 0354 10mg | 99.68% APEXBIO TECHNOLOGY LLC IKKβ inhibitor Immunology/Inflammation|IκB/IKK More Information Supplier Page × IMD 0354